Amy Doherty

Deputy Director, ENVISION


  • MS, Business Management, University of Maryland University College
  • Master’s Certificate, Organizational Leadership, Villanova University
  • BS, Social and Behavioral Sciences, University of Southern Maine

Amy Doherty has nearly 20 years of experience in designing, starting, and managing international development projects. She is keenly interested in working to address gaps in host-country capacity to implement neglected tropical disease (NTD) control and elimination strategies. She regularly contributes to the World Health Organization (WHO) Working Group on Capacity Strengthening for NTDs, which supports curriculum development and planning of numerous training programs to strengthen and standardize program management and technical approaches for neglected tropical diseases.  

In her current role, Ms. Doherty works extensively with the U.S. Agency for International Development (USAID) on ENVISION, a project that supports 14 countries working to control and eliminate seven NTDs by the year 2020. As chief advisor to USAID on its annual procurement of praziquantel—an antihelmintic drug used to treat schistosomiasis—she coordinates with the WHO, Merck and other NTD implementers to ensure that global praziquantel supply meets the projected demand of endemic countries implementing deworming programs at national scale. In 2014, USAID projects alone supported the distribution of praziquantel to more than 2 million people.

Ms. Doherty has worked with a range of different clients, including the U.S. Department of Labor, U.S. Department of Defense, World Bank, Asian Development Bank, U.K. Department for International Development, U.S. Centers for Disease Control and Prevention, National Institutes of Health, and various foundations.